市场调查报告书
商品编码
1361116
家庭滥用药物 (DOA) 测试市场规模 - 按类型(测试杯、测试条)、按样本类型(唾液、尿液、血液)和 2023 年 - 2032 年全球预测At-home Drug of Abuse (DOA) Testing Market Size - By Type (Test Cups, Test Strips), By Sample Type (Saliva, Urine, Blood) & Global Forecast 2023 - 2032 |
由于人们越来越认识到药物筛检在维护公共安全和确保劳动力健康方面发挥的关键作用,预计 2023 年至 2032 年家庭药物滥用 (DOA) 检测市场规模将达到 7% 的复合年增长率。例如,马萨诸塞州启动了许多减少危害的计划,透过这些计划分发甲苯噻嗪试纸。由于该药物能够造成皮肤伤口,过量服用还会导致死亡,因此药物筛选起着重要作用。
随着药物滥用现象的日益普遍,雇主越来越多地对员工采取药物检测政策,而父母和个人也将其用于特定目的。这种意识的提高导致对家用药物检测套件的需求更大。
整个家庭滥用药物检测市场根据类型、样本类型和地区进行划分。
预计从 2023 年到 2032 年,测试杯细分市场的复合年增长率将达到 7.3% 左右,因为它们为药物筛选提供了一种用户友好的一体化解决方案,使流程更加简单且不易出错。同时,製造商不断推出新功能,例如整合温度条、掺假检查以及同时测试多种药物的能力。测试杯反映了人们对可在家中轻鬆执行的具有成本效益且高效的药物测试解决方案的渴望。
由于人们对非侵入性和无痛检测方法的日益青睐,预计 2023 年至 2032 年血液样本领域的复合年增长率将达到 7.3%。传统的尿液检测有时会让人感到不舒服且具侵入性,尤其是在家庭环境中。血液样本检测提供了一种侵入性较小、更谨慎且可以提供准确结果的替代方案。随着技术的不断进步,血液样本检测预计将变得更加用户友好和方便,有利于该细分市场的成长。
由于人们越来越重视健康和安全,尤其是在工作场所和教育机构,亚太地区家庭滥用药物检测市场规模预计到 2032 年复合年增长率将达到 8.2%。该地区各国政府和组织正在认识到定期进行药物筛检以应对药物滥用问题的必要性。快速的城市化和可支配收入的增加,使更多人更容易获得家庭药物检测套件,这将积极影响亚太地区的市场动态。
At-home drug of abuse (DOA) testing market size is predicted to record 7% CAGR from 2023 to 2032 due to the increasing awareness and recognition of the critical role that drug screening plays in maintaining public safety and ensuring a healthy workforce. For instance, Massachusetts has launched many harm reduction programs through which test strips for xylazine is being distributed. As the drug has the capability of producing gaping skin wounds and can also cause death in case of overdose, drug screening plays a major role.
With rising prevalence of substance abuse, employers are increasingly adopting drug testing policies for employees, while parents and individuals are also using it for specific purposes. This heightened awareness has led to greater demand for at-home drug testing kits.
The overall at-home drug of abuse testing market is divided based on type, sample type, and region.
The test cups segment is predicted to observe around 7.3% CAGR from 2023 to 2032 as they offer a user-friendly, all-in-one solution for drug screening, making the process more straightforward and less prone to errors. Simultaneously, manufacturers are constantly introducing new features, such as integrated temperature strips, adulteration checks, and the ability to test for multiple drugs simultaneously. Test cups reflects the desire for cost-effective and efficient drug testing solutions that can be easily performed at home.
The blood sample segment is expected to record 7.3% CAGR from 2023 to 2032 due to the growing preference for non-invasive and painless testing methods. Traditional urine-based testing can sometimes be uncomfortable and invasive, especially in at-home settings. Blood sample testing provides an alternative that is less invasive, more discreet, and can offer accurate results. As technology continues to advance, blood sample testing is expected to become even more user-friendly and accessible, favoring the segment growth.
Asia Pacific at-home drug of abuse testing market size is anticipated to witness 8.2% CAGR through 2032 driven by an increased emphasis on health and safety, especially in the workplace and educational institutions. Governments and organizations in the region are recognizing the need for regular drug screening to combat substance abuse issues. The rapid urbanization and increased disposable income, which make at-home drug testing kits more accessible to a wider population, will positively sway the APAC market dynamics.